5735.Full.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Protein Kinase D Interaction with TLR5 Is Required for Inflammatory Signaling in Response to Bacterial Flagellin This information is current as Sabine M. Ivison, Nicholas R. Graham, Cecily Q. Bernales, of September 28, 2021. Arnawaz Kifayet, Natalie Ng, Leila A. Shobab and Theodore S. Steiner J Immunol 2007; 178:5735-5743; ; doi: 10.4049/jimmunol.178.9.5735 http://www.jimmunol.org/content/178/9/5735 Downloaded from References This article cites 39 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/178/9/5735.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Protein Kinase D Interaction with TLR5 Is Required for Inflammatory Signaling in Response to Bacterial Flagellin1 Sabine M. Ivison, Nicholas R. Graham, Cecily Q. Bernales, Arnawaz Kifayet, Natalie Ng, Leila A. Shobab, and Theodore S. Steiner2 Protein kinase D (PKD), also called protein kinase C (PKC)␮, is a serine-threonine kinase that is involved in diverse areas of cellular function such as lymphocyte signaling, oxidative stress, and protein secretion. After identifying a putative PKD phos- phorylation site in the Toll/IL-1R domain of TLR5, we explored the role of this kinase in the interaction between human TLR5 and enteroaggregative Escherichia coli flagellin in human epithelial cell lines. We report several lines of evidence that implicate PKD in TLR5 signaling. First, PKD phosphorylated the TLR5-derived target peptide in vitro, and phosphorylation of the putative target serine 805 in HEK 293T cell-derived TLR5 was identified by mass spectrometry. Furthermore, mutation of serine 805 to alanine abrogated responses of transfected HEK 293T cells to flagellin. Second, TLR5 interacted with PKD in coimmunoprecipi- Downloaded from tation experiments, and this association was rapidly enhanced by flagellin treatment. Third, pharmacologic inhibition of PKC or PKD with Go¨6976 resulted in reduced expression and secretion of IL-8 and prevented the flagellin-induced activation of p38 MAPK, but treatment with the PKC inhibitor Go¨6983 had no significant effects on these phenotypes. Finally, involvement of PKD in the p38-mediated IL-8 response to flagellin was confirmed by small hairpin RNA-mediated gene silencing. Together, these results suggest that phosphorylation of TLR5 by PKD may be one of the proximal elements in the cellular response to flagellin, and that this event contributes to p38 MAPK activation and production of inflammatory cytokines in epithelial cells. The Journal http://www.jimmunol.org/ of Immunology, 2007, 178: 5735–5743. ince the discovery that TLR4 initiates an inflammatory naling adaptors such as MyD88 or TIR domain-containing adap- response after recognition of bacterial LPS (1), the interest tor-inducing IFN-␤. In the MyD88-dependent pathway common to S in these pattern recognition receptors and their signaling most TLRs, receptor ligation results in phosphorylation and acti- pathways has been intense. In homodimeric or heterodimeric form, vation of IL-1R-associated kinase family members, allowing the TLRs respond to peptidoglycans, lipoproteins, LPS, dsRNA, un- recruitment of the adaptor TNFR-associated factor 6, which acti- methylated CpG-DNA, and bacterial flagellin. Ligation of these vates the TGF-␤-activated kinase 1. The latter then activates the by guest on September 28, 2021 innate immune receptors, which are poised on surface or organellar transcription factors NF-␬B (via I-␬B degradation) and AP-1 (via membranes of many cell types, including epithelial cells, macro- p38 MAPK and JNK), leading to cytokine and chemokine expres- phages and dendritic cells, initiates signaling cascades that trigger sion (reviewed in Ref. 2). secretion of inflammatory cytokines and chemokines as well as TLR5, which recognizes bacterial flagellin, is thought to trans- expression of costimulatory signals for adaptive immunity. duce signals via the MyD88-dependent pathway only (3, 4). Ac- TLRs are characterized by N-terminal leucine-rich repeats, a tivation of IL-1R-associated kinase (5), nuclear translocation of central transmembrane domain, and a cytosolic C-terminal Toll/ NF-␬B (6, 7), and activation of MEK (8), p38 MAPK, and ERK 3 IL-1R (TIR) domain, which links the receptor to proximal sig- (6) have all been demonstrated after flagellin treatment in many cell types, including professional APCs and epithelial cells. These pathways lead to the secretion of ␤-defensin (9), cytokines IL-6 Division of Infectious Diseases, University of British Columbia, Vancouver, British ␣ ␣ Columbia, Canada and TNF- (10), and/or chemokines MIP3 and IL-8 (3, 4), which Received for publication March 20, 2006. Accepted for publication February recruit and activate dendritic cells and neutrophils, respectively. 21, 2007. However, the characteristic features of TLR5 signaling that confer The costs of publication of this article were defrayed in part by the payment of page specific responses to flagellin as opposed to other TLR agonists charges. This article must therefore be hereby marked advertisement in accordance have yet to be identified. with 18 U.S.C. Section 1734 solely to indicate this fact. Using an in silico analysis to identify potential protein interac- 1 This work was supported by Grant 992840.01 from Burroughs-Wellcome Career Award in Biomedical Sciences, Operating Grant 64355 from the Canadian Institutes tion sites in the TIR domain of TLR5, we identified a putative for Health Research, by the Canada Foundation for Innovation New Opportunities protein kinase D (PKD) phosphorylation site (see Fig. 1A). PKD is Fund 4453, by New Investigator Awards from the Canadian Institutes for Health a serine-threonine kinase of the calmodulin-calcium-dependent ki- Research, and by the Vancouver Coastal Health Research Institute “In It for Life” Fund (to T.S.S.). nase family, and contains diacylglycerol-binding and pleckstrin 2 Address correspondence and reprint requests to Dr. Theodore S. Steiner, Division of homology domains within its regulatory N-terminal region. The Infectious Diseases, University of British Columbia, Room D452, Heather Pavilion three known PKD subtypes PKD1 (also called protein kinase East, 2733 Heather Street, Vancouver V5Z 3J5, British Columbia, Canada. E-mail ␮ ␯ address: [email protected] C (PKC) ), PKD2, and PKD3 (PKC ) are involved in diverse aspects of cellular function including membrane trafficking, dif- 3 Abbreviations used in this paper: TIR, Toll/IL-1R; PKD, protein kinase D; PKC, protein kinase C; FliC, flagellin; PDB, phorbol 12,13-dibutyrate; shRNA, small hair- ferentiation, proliferation, and apoptosis as well as the responses to pin RNA; siRNA, small interfering RNA; HEK, human embryonic kidney; HA, hem- BCR and TCR ligation, regulatory peptides, and oxidative stress agglutinin; shRNA, small hairpin RNA; Ct, cycle threshold. (see reviews Refs. 11, 12). Using the interaction between the en- Copyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00 teroaggregative Escherichia coli H18 flagellin (FliC) and human www.jimmunol.org 5736 PKD IN TLR5 SIGNALING ␮ TLR5 in epithelial cell lines as a model, we report that PKD in- at a final concentration of 0.5–1 g/ml, while Pam3CysSK4 (EMC Micro- teracts with TLR5, and that this kinase is required for transducing collections) was used at 10 ␮g/ml. Cells were pretreated with inhibitors or flagellin-stimulated inflammatory responses. DMSO vehicle for 1 h, followed by stimulation for varied amounts of time, depending on cell type and readout. For detection of PKD, cells were lysed in 50 mM Tris-HCl (pH 7.4), 1% Materials and Methods Triton X-100, 150 mM NaCl, 5 mM EDTA (pH 7.4), and Protease Inhib- Abs and vectors itor Cocktail for mammalian cells (Sigma-Aldrich). For detection of phos- phorylated proteins, cells were lysed in 20 mM Tris (pH 7.5), 150 mM The following Abs were used: anti-PK (Serotec), anti-PKD1, anti- NaCl, 1 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 2.5 mM sodium phospho-PKD1 (S916), anti-phospho-p38 MAPK (T180/Y182), anti- ␤ pyrophosphate, 1 mM -glycerophosphate, 2 mM Na3VO4, and Protease total p38 (Cell Signaling Technology), and anti-GAPDH (Fitzgerald Inhibitor Cocktail. Equal amounts of proteins were separated by SDS- Industries International). PAGE and blotted for Western blot analysis. TLR5 cloned into pEF6-V5His-Topo (Invitrogen Life Technologies) For analysis of secreted IL-8, in the case of Caco-2 cells, culture me- was a gift from A. Aderem (Institute for Systems Biology, Seattle, WA). dium was removed after3hofstimulus. For HEK 293T cells, longer time pEGFP was from BD Clontech. Hemagglutinin (HA)-PKD1 and points (6 or 24 h) were used due to the slower kinetics of IL-8 production. pSPKD1-1 were provided by A. Toker (Harvard University, Boston, MA). The IL-8 contents of supernatants were determined by ELISA (OptEIA; The IL-8pLuc reporter vector (13) was provided by B. Salh (University of BD Biosciences). British Columbia, Vancouver, British Columbia, Canada). The TLR5 S805A mutant was produced by the quick-change circular In vitro kinase assays mutagenesis method (Stratagene), using the following primers: 5Ј-gtac cagttgatgaaacatcaagcccatcagaggctttgtacag and 5Ј-ctgtacaaagcctctgatgg The synthetic peptides purchased from GenScript and dissolved at 3 mM in cttgatgtttcatcaactggtac.
Recommended publications
  • Construction and Loss of Bacterial Flagellar Filaments

    Construction and Loss of Bacterial Flagellar Filaments

    biomolecules Review Construction and Loss of Bacterial Flagellar Filaments Xiang-Yu Zhuang and Chien-Jung Lo * Department of Physics and Graduate Institute of Biophysics, National Central University, Taoyuan City 32001, Taiwan; [email protected] * Correspondence: [email protected] Received: 31 July 2020; Accepted: 4 November 2020; Published: 9 November 2020 Abstract: The bacterial flagellar filament is an extracellular tubular protein structure that acts as a propeller for bacterial swimming motility. It is connected to the membrane-anchored rotary bacterial flagellar motor through a short hook. The bacterial flagellar filament consists of approximately 20,000 flagellins and can be several micrometers long. In this article, we reviewed the experimental works and models of flagellar filament construction and the recent findings of flagellar filament ejection during the cell cycle. The length-dependent decay of flagellar filament growth data supports the injection-diffusion model. The decay of flagellar growth rate is due to reduced transportation of long-distance diffusion and jamming. However, the filament is not a permeant structure. Several bacterial species actively abandon their flagella under starvation. Flagellum is disassembled when the rod is broken, resulting in an ejection of the filament with a partial rod and hook. The inner membrane component is then diffused on the membrane before further breakdown. These new findings open a new field of bacterial macro-molecule assembly, disassembly, and signal transduction. Keywords: self-assembly; injection-diffusion model; flagellar ejection 1. Introduction Since Antonie van Leeuwenhoek observed animalcules by using his single-lens microscope in the 18th century, we have entered a new era of microbiology.
  • Covalent Flexible Peptide Docking in Rosetta

    Covalent Flexible Peptide Docking in Rosetta

    bioRxiv preprint doi: https://doi.org/10.1101/2021.05.06.441297; this version posted May 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Covalent Flexible Peptide Docking in Rosetta Barr Tivon1,#, Ronen Gabizon1,#, Bente A. Somsen2, Peter J. Cossar2, Christian Ottmann2 , Nir London1,* 1 Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel 2 Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, The Netherlands # equal contribution * Corresponding author: [email protected] Keywords: Covalent peptides; peptide docking; CovPepDock; FlexPepDock; 14-3-3; Electrophilic peptides; bioRxiv preprint doi: https://doi.org/10.1101/2021.05.06.441297; this version posted May 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Electrophilic peptides that form an irreversible covalent bond with their target have great potential for binding targets that have been previously considered undruggable. However, the discovery of such peptides remains a challenge. Here, we present CovPepDock, a computational pipeline for peptide docking that incorporates covalent binding between the peptide and a receptor cysteine. We applied CovPepDock retrospectively to a dataset of 115 disulfide-bound peptides and a dataset of 54 electrophilic peptides, for which it produced a top-five scoring, near-native model, in 89% and 100% of the cases, respectively.
  • A Global Review on Short Peptides: Frontiers and Perspectives †

    A Global Review on Short Peptides: Frontiers and Perspectives †

    molecules Review A Global Review on Short Peptides: Frontiers and Perspectives † Vasso Apostolopoulos 1 , Joanna Bojarska 2,* , Tsun-Thai Chai 3 , Sherif Elnagdy 4 , Krzysztof Kaczmarek 5 , John Matsoukas 1,6,7, Roger New 8,9, Keykavous Parang 10 , Octavio Paredes Lopez 11 , Hamideh Parhiz 12, Conrad O. Perera 13, Monica Pickholz 14,15, Milan Remko 16, Michele Saviano 17, Mariusz Skwarczynski 18, Yefeng Tang 19, Wojciech M. Wolf 2,*, Taku Yoshiya 20 , Janusz Zabrocki 5, Piotr Zielenkiewicz 21,22 , Maha AlKhazindar 4 , Vanessa Barriga 1, Konstantinos Kelaidonis 6, Elham Mousavinezhad Sarasia 9 and Istvan Toth 18,23,24 1 Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia; [email protected] (V.A.); [email protected] (J.M.); [email protected] (V.B.) 2 Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland 3 Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; [email protected] 4 Botany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt; [email protected] (S.E.); [email protected] (M.A.) 5 Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland; [email protected] (K.K.); [email protected] (J.Z.) 6 NewDrug, Patras Science Park, 26500 Patras, Greece; [email protected] 7 Department of Physiology and Pharmacology,
  • RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)

    RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)

    RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Human Toll-Like Receptor Signaling Pathway Cat. no. 330231 PAHS-018ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Human Toll-Like Receptor (TLR) Signaling Pathway RT² Profiler PCR Array profiles the expression of 84 genes central to TLR-mediated signal transduction and innate immunity. The TLR family of pattern recognition receptors (PRRs) detects a wide range of bacteria, viruses, fungi and parasites via pathogen-associated molecular patterns (PAMPs). Each receptor binds to specific ligands, initiates a tailored innate immune response to the specific class of pathogen, and activates the adaptive immune response.
  • Human Alkaline Phosphatase Dephosphorylates Microbial Products and Is Elevated in Preterm Neonates with a History of Late-Onset Sepsis

    Human Alkaline Phosphatase Dephosphorylates Microbial Products and Is Elevated in Preterm Neonates with a History of Late-Onset Sepsis

    RESEARCH ARTICLE Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsis Matthew Pettengill1,2, Juan D. Matute2, Megan Tresenriter3, Julie Hibbert4, David Burgner5,6,7, Peter Richmond6, Jose Luis MillaÂn8, Al Ozonoff2, Tobias Strunk4, Andrew Currie4,9, Ofer Levy1,2* a1111111111 a1111111111 1 Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, United States of America, 2 Harvard Medical School, Boston, Massachusetts, United States a1111111111 of America, 3 University of California Davis School of Medicine, Davis, California, United States of America, a1111111111 4 The University of Western Australia, Crawley, Western Australia, Australia, 5 Murdoch Children's a1111111111 Research Institute, Parkville, Victoria, Australia, 6 Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia, 7 Department of Paediatrics, Monash University, Clayton, Victoria, Australia, 8 Sanford Children's Health Research Center, Sanford-Burnham Medical Research Institute, LaJolla, California, United States of America, 9 School of Veterinary & Life Sciences, Murdoch University, Murdoch, Western Australia, Australia OPEN ACCESS * [email protected] Citation: Pettengill M, Matute JD, Tresenriter M, Hibbert J, Burgner D, Richmond P, et al. (2017) Human alkaline phosphatase dephosphorylates Abstract microbial products and is elevated in preterm neonates with a history of late-onset sepsis. PLoS ONE 12(4): e0175936. https://doi.org/10.1371/ journal.pone.0175936 Background Editor: Olivier Baud, Hopital Robert Debre, FRANCE A host defense function for Alkaline phosphatases (ALPs) is suggested by the contribution of intestinal ALP to detoxifying bacterial lipopolysaccharide (endotoxin) in animal models in Received: July 6, 2016 vivo and the elevation of ALP activity following treatment of human cells with inflammatory Accepted: April 3, 2017 stimuli in vitro.
  • A Technology Platform to Test the Efficacy of Purification of Alginate

    A Technology Platform to Test the Efficacy of Purification of Alginate

    Materials 2014, 7, 2087-2103; doi:10.3390/ma7032087 OPEN ACCESS materials ISSN 1996-1944 www.mdpi.com/journal/materials Article A Technology Platform to Test the Efficacy of Purification of Alginate Genaro A. Paredes-Juarez *, Bart J. de Haan, Marijke M. Faas and Paul de Vos Department of Pathology and Medical Biology, Section of Immunoendocrinology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, EA11, 9700 RB Groningen, The Netherlands; E-Mails: [email protected] (B.J.H.); [email protected] (M.M.F.); [email protected] (P.V.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +31-50-3615-180; Fax: 31-50-3619-911. Received: 10 January 2014; in revised form: 12 February 2014 / Accepted: 5 March 2014 / Published: 12 March 2014 Abstract: Alginates are widely used in tissue engineering technologies, e.g., in cell encapsulation, in drug delivery and various immobilization procedures. The success rates of these studies are highly variable due to different degrees of tissue response. A cause for this variation in success is, among other factors, its content of inflammatory components. There is an urgent need for a technology to test the inflammatory capacity of alginates. Recently, it has been shown that pathogen-associated molecular patterns (PAMPs) in alginate are potent immunostimulatories. In this article, we present the design and evaluation of a technology platform to assess (i) the immunostimulatory capacity of alginate or its contaminants, (ii) where in the purification process PAMPs are removed, and (iii) which Toll-like receptors (TLRs) and ligands are involved.
  • An Immunologist's Perspective on Nutrition, Immunity, and Infectious

    An Immunologist's Perspective on Nutrition, Immunity, and Infectious

    © 2009 Poultry Science Association, Inc. An immunologist’s perspective on nutrition, immunity, and infectious diseases: 1 Introduction and overview M. H. Kogut *2 and K. Klasing † * Southern Plains Agricultural Research Center, USDA-ARS, College Station, TX 77845; and † Department of Avian Sciences, University of California, Davis 95616 Primary Audience: Poultry Nutritionists, Immunologists, Veterinarians, Researchers SUMMARY The immune system is a multifaceted arrangement of membranes (skin, epithelial, and mucus), cells, and molecules whose function is to eradicate invading pathogens or cancer cells from a host. Working together, the various components of the immune system perform a balancing act of being lethal enough to kill pathogens or cancer cells yet specific so as not to cause extensive damage to “self” tissues of the host. A functional immune system is a requirement of a healthy life in modern animal production. Yet infectious diseases still represent a serious drain on the economics (reduced production, cost of therapeutics, and vaccines) and welfare of animal agriculture. The interaction involving nutrition and immunity and how the host deals with infectious agents is a strategic deter- minant in animal health. Almost all nutrients in the diet play a fundamental role in sustaining an op- timal immune response, such that deficient and excessive intakes can have negative consequences on immune status and susceptibility to a variety of pathogens. Dietary components can regulate physiological functions of the body; interacting with the immune response is one of the most im- portant functions of nutrients. The pertinent question to be asked and answered in the current era of poultry production is whether the level of nutrients that maximizes production in commercial diets is sufficient to maintain competence of immune status and disease resistance.
  • 1 Design and Production of Specifically and with High Affinity

    1 Design and Production of Specifically and with High Affinity

    1 Design and Production of Specifically and with High Affinity Reacting Peptides (SHARP®-s) by Jan C Biro HOMULUS FOUNDATION, 612 S. Flower Str., #1220, 90017 CA, USA [email protected] www.janbiro.com 2 Abstract Background A partially random target selection method was developed to design and produce affinity reagents (target) to any protein query. It is based on the recent concept of Proteomic Code (for review see Biro, 2007 [1]) which suggests that significant number of amino acids in specifically interacting proteins are coded by partially complementary codons. It means that the 1st and 3rd residues of codons coding many co-locating amino acids are complementary but the 2nd may but not necessarily complementary: like 5’-AXG-3’/3’-CXT-5’ codon pair, where X is any nucleotide. Results A mixture of 45 residue long, reverse, partially complementary oligonucleotide sequences (target pool) were synthesized to selected epitopes of query mRNA sequences. The 2nd codon residues were randomized. The target oligonucleotide pool was inserted into vectors, expressed and the protein products were screened for affinity to the query in Bacterial Two-Hybrid System. The best clones were used for larger-scale protein syntheses and characterization. It was possible to design and produce specific and with high affinity reacting (Kd: ~100 nM) oligopeptide reagents to GAL4 query oligopeptides. Conclusions Second codon residue randomization is a promising method to design and produce affinity peptides to any protein sequences. The method has the potential to be a rapid, inexpensive, high throughput, non-immunoglobulin based alternative to recent in vivo antibody generating procedures.
  • Crystal Structure of Bacillus Cereus Flagellin and Structure-Guided Fusion-Protein Designs

    Crystal Structure of Bacillus Cereus Flagellin and Structure-Guided Fusion-Protein Designs

    www.nature.com/scientificreports OPEN Crystal structure of Bacillus cereus fagellin and structure-guided fusion-protein designs Received: 6 February 2018 Meong Il Kim1, Choongdeok Lee1, Jaewan Park1, Bo-Young Jeon2 & Minsun Hong1 Accepted: 23 March 2018 Flagellin is a major component of the fagellar flament. Flagellin also functions as a specifc ligand Published: xx xx xxxx that stimulates innate immunity through direct interaction with Toll-like receptor 5 (TLR5) in the host. Because fagellin activates the immune response, it has been of interest to develop as a vaccine adjuvant in subunit vaccines or antigen fusion vaccines. Despite the widespread application of fagellin fusion in preventing infectious diseases, fagellin-antigen fusion designs have never been biophysically and structurally characterized. Moreover, fagellin from Salmonella species has been used extensively despite containing hypervariable regions not required for TLR5 that can cause an unexpected immune response. In this study, fagellin from Bacillus cereus (BcFlg) was identifed as the smallest fagellin molecule containing only the conserved TLR5-activating D0 and D1 domains. The crystal structure of BcFlg was determined to provide a scheme for fusion designs. Through homology-based modeling and comparative structural analyses, diverse fusion strategies were proposed. Moreover, cellular and biophysical analysis of an array of fusion constructs indicated that insertion fusion at BcFlg residues 178–180 does not interfere with the protein stability or TLR5-stimulating capacity of fagellin, suggesting its usefulness in the development and optimization of fagellin fusion vaccines. Flagella enable bacterial locomotion toward favorable conditions or away from unfavorable environments. Te bacterial fagellum transverses from the cytoplasm to the outside of the bacterium and comprises more than 30 diferent proteins1,2.
  • DNA Vaccine-Encoded Flagellin Can Be Used As an Adjuvant Scaffold to Augment HIV-1 Gp41 Membrane Proximal External Region Immunogenicity

    DNA Vaccine-Encoded Flagellin Can Be Used As an Adjuvant Scaffold to Augment HIV-1 Gp41 Membrane Proximal External Region Immunogenicity

    viruses Article DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity Lara Ajamian 1,2, Luca Melnychuk 1,2, Patrick Jean-Pierre 1 and Gerasimos J. Zaharatos 1,3,* ID 1 Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada; [email protected] (L.A.); [email protected] (L.M.); [email protected] (P.J.-P.) 2 Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada 3 Division of Infectious Disease, Department of Medicine & Division of Medical Microbiology, Department of Clinical Laboratory Medicine, Jewish General Hospital, Montréal, QC H3T 1E2, Canada * Correspondence: [email protected]; Tel.: +1-514-340-8294 Received: 28 January 2018; Accepted: 23 February 2018; Published: 27 February 2018 Abstract: Flagellin’s potential as a vaccine adjuvant has been increasingly explored over the last three decades. Monomeric flagellin proteins are the only known agonists of Toll-like receptor 5 (TLR5). This interaction evokes a pro-inflammatory state that impacts upon both innate and adaptive immunity. While pathogen associated molecular patterns (PAMPs) like flagellin have been used as stand-alone adjuvants that are co-delivered with antigen, some investigators have demonstrated a distinct advantage to incorporating antigen epitopes within the structure of flagellin itself. This approach has been particularly effective in enhancing humoral immune responses. We sought to use flagellin as both scaffold and adjuvant for HIV gp41 with the aim of eliciting antibodies to the membrane proximal external region (MPER).
  • Activation of Toll-Like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth

    Activation of Toll-Like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth

    Published OnlineFirst March 22, 2011; DOI: 10.1158/0008-5472.CAN-10-1993 Cancer Microenvironment and Immunology Research Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth Zhenyu Cai, Amir Sanchez, Zhongcheng Shi, Tingting Zhang, Mingyao Liu, and Dekai Zhang Abstract Increasing evidence showed that Toll-like receptors (TLR), key receptors in innate immunity, play a role in cancer progression and development but activation of different TLRs might exhibit the exact opposite outcome, antitumor or protumor effects. TLR function has been extensively studied in innate immune cells, so we investigated the role of TLR signaling in breast cancer epithelial cells. We found that TLR5 was highly expressed in breast carcinomas and that TLR5 signaling pathway is overly responsive in breast cancer cells. Interestingly, flagellin/TLR5 signaling in breast cancer cells inhibits cell proliferation and an anchorage-independent growth, a hallmark of tumorigenic transformation. In addition, the secretion of soluble factors induced by flagellin contributed to the growth-inhibitory activity in an autocrine fashion. The inhibitory activity was further confirmed in mouse xenografts of human breast cancer cells. These findings indicate that TLR5 activation by flagellin mediates innate immune response to elicit potent antitumor activity in breast cancer cells themselves, which may serve as a novel therapeutic target for human breast cancer therapy. Cancer Res; 71(7); 1–10. Ó2011 AACR. Introduction (16, 17). Thus, the function and biological importance of TLRs expressed on various tumor cells seem complex. Toll-like receptors (TLR) are membrane-bound receptors Unlike other TLR family members, TLR5 is not expressed on that play key roles in both the innate and adaptive immune mouse macrophages and conventional dendritic cells (DC).
  • Bacterial Flagellin—A Potent Immunomodulatory Agent

    Bacterial Flagellin—A Potent Immunomodulatory Agent

    OPEN Experimental & Molecular Medicine (2017) 49, e373; doi:10.1038/emm.2017.172 Official journal of the Korean Society for Biochemistry and Molecular Biology www.nature.com/emm REVIEW Bacterial flagellin—a potent immunomodulatory agent Irshad A Hajam1, Pervaiz A Dar2, Imam Shahnawaz2, Juan Carlos Jaume2 and John Hwa Lee1 Flagellin is a subunit protein of the flagellum, a whip-like appendage that enables bacterial motility. Traditionally, flagellin was viewed as a virulence factor that contributes to the adhesion and invasion of host cells, but now it has emerged as a potent immune activator, shaping both the innate and adaptive arms of immunity during microbial infections. In this review, we summarize our understanding of bacterial flagellin and host immune system interactions and the role flagellin as an adjuvant, anti-tumor and radioprotective agent, and we address important areas of future research interests. Experimental & Molecular Medicine (2017) 49, e373; doi:10.1038/emm.2017.172; published online 1 September 2017 INTRODUCTION vaccines. Even though all the adjuvants studied so far have The immune system has evolved to fight off microbial invasion proven to be effective, flagellin, a TLR5 agonist, has been through the coordinated action of the innate and adaptive arms shown more promising results without any major side effects. of the immunity. Innate immune cells respond to a variety of Flagellin is the structural component of the flagellum, a stimuli, including bacterial, viral, parasitic or fungal infections, locomotory organ that is mostly associated with Gram-negative via members of structurally related receptors termed toll-like bacteria. It is characterized by highly conserved N- and receptors (TLRs).